SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRNPRNewsWire • 12/21/21
AMRN FINAL DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages Amarin Corporation plc Investors to Secure Counsel Before Important Thursday Deadline in Securities Class Action - AMRNNewsfile Corp • 12/20/21
ROSEN, A LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses in Excess of $100K to Secure Counsel Before Important December 23 Deadline in Securities Class Action - AMRNPRNewsWire • 12/14/21
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Amarin Corporation plc Investors to Secure Counsel Before Important December 23 Deadline in Securities Class Action - AMRNNewsfile Corp • 12/07/21
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Amarin Corporation Plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of December 23, 2021 - AMRNNewsfile Corp • 12/05/21
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNewsfile Corp • 12/04/21
AMRN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of December 23, 2021 in the Class Action Filed on Behalf of Amarin Corporation Plc Limited ShareholdersNewsfile Corp • 12/03/21
Levi & Korsinsky, LLP, Researching Possible Securities Law Violations - Amarin Corporation Plc -AMRNPRNewsWire • 11/24/21
Rosen, a Respected And Leading Firm, Encourages Amarin Corporation plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - AMRNNewsfile Corp • 11/24/21
Rosen, Top Ranked Investor Counsel, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMRNNewsfile Corp • 11/18/21
Amarin Reports Overview of Latest Clinical Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) and Eicosapentaenoic Acid (EPA) Presented at the American Heart Association Scientific Sessions 2021GlobeNewsWire • 11/16/21
SHAREHOLDER ALERT: AMRN ONTF NVAX: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesAccesswire • 11/16/21
ROSEN, A LEADING LAW FIRM, Encourages Amarin Corporation plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - AMRNNewsfile Corp • 11/12/21
CLASS ACTION UPDATE for NNOX, AMRN and RECAF: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersAccesswire • 11/11/21
AMARIN ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Amarin Corporation PLC and Encourages Investors to Contact the FirmBusiness Wire • 11/11/21
AMRN INVESTOR NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Amarin Corporation plc Investors With Losses to Secure Counsel Before Important Deadline in Securities Class Action – AMRNBusiness Wire • 11/10/21
SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against Amarin Corporation, plc and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNewsfile Corp • 11/08/21
Latest Research Evaluating VASCEPA®/VAZKEPA (Icosapent Ethyl) to be Presented at American Heart Association Scientific Sessions 2021GlobeNewsWire • 11/08/21